Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Retirement saving: I think AstraZeneca could help you to accumulate £1 million

| Peter Stephens

AstraZeneca plc (LON: AZN) may offer a mix of income and growth potential which could boost your retirement prospects in…

Read more »

Investing Articles

2 FTSE 100 shares to buy for the next 10 years that I think could make you richer

| Andy Ross

Andy Ross explains why he thinks these two FTSE 100 (INDEXFTSE:UKX) companies are great picks to hold for the next…

Read more »

Investing Articles

Here’s why the AstraZeneca share price is flying today

| Paul Summers

Shares in pharma giant AstraZeneca plc (LON:AZN) jumped on encouraging full-year results. Should new investors be tempted to buy?

Read more »

Investing Articles

Have £1k to invest? Here’s one FTSE 100 stock I’d buy before anything else

| Rupert Hargreaves

Rupert Hargreaves runs his eye over a FTSE 100 (INDEXFTSE: UKX) income hero with a bright future.

Read more »

Investing Articles

Why I’d avoid the AstraZeneca share price and buy this FTSE 250 dividend stock

| Roland Head

AstraZeneca plc (LON:AZN) could leave your portfolio feeling poorly, says Roland Head, who suggests an opportunity in the FTSE 250…

Read more »

Investing Articles

Why I think the AstraZeneca share price could crush the FTSE 100 this year

| Peter Stephens

AstraZeneca plc (LON: AZN) appears to offer better value for money than the FTSE 100.

Read more »

Investing Articles

Will AstraZeneca continue to outperform in 2019?

| Andy Ross

Andy Ross sees plenty to be upbeat about at AstraZeneca plc (LON:AZN) that he thinks could keep it beating the…

Read more »

Investing Articles

Why I’d pick the GSK and AstraZeneca share prices to beat my State Pension

| Alan Oscroft

I'm looking to re-invest a company pension, and here's why AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) shares…

Read more »

Investing Articles

The AstraZeneca and GSK share prices look like buys to me as the FTSE 100 crashes

| Harvey Jones

Harvey Jones says AstraZeneca plc (LON: AZN) and GlaxoSmithKline plc (LON: GSK) have the antidote to the current FTSE 100…

Read more »

Investing Articles

I think this FTSE 100 dividend stock could be poised for big gains in 2019

| Royston Wild

Royston Wild identifies a FTSE 100 (INDEXFTSE: UKX) income hero that could sprint still higher in 2019.

Read more »

Investing Articles

The AstraZeneca share price has smashed the FTSE 100 in 2018. I say it could do so again in 2019

| Rupert Hargreaves

Rupert Hargreaves explains why he thinks AstraZeneca plc (LON:AZN) will continue to outperform the FTSE 100 (INDEXFTSE: UKX).

Read more »

Investing Articles

Why I think AstraZeneca should be in your 2019 share portfolio

| Tezcan Gecgil, PhD

AstraZeneca plc (LON: AZN) has multiple positive catalysts and I see a buying opportunity right now.

Read more »